We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
-$138M
Cap. Flow %
-2.91%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.53%
3 Financials 11.99%
4 Real Estate 8.48%
5 Materials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KIDS icon
276
OrthoPediatrics
KIDS
$596M
$1.98M 0.04%
45,219
-4,427
-9% -$204K
DYN icon
277
Dyne Therapeutics
DYN
$4.83B
$1.98M 0.04%
175,752
-849
-0.5% -$10K
FRBN
278
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
$1.94M 0.04%
181,263
-4,086
-2% -$43.3K
WEL
279
DELISTED
Integrated Wellness Acquisition Corp
WEL
$1.94M 0.04%
181,263
-4,086
-2% -$43.5K
HCMA
280
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
$1.93M 0.04%
181,263
-4,086
-2% -$43K
ARCB icon
281
ArcBest
ARCB
$3.02B
$1.93M 0.04%
+19,540
New +$1.75M
LBPH
282
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$1.93M 0.04%
262,265
+32,265
+14% +$244K
NBR icon
283
PUT
Nabors Industries
NBR
$1.23B
$1.92M 0.04%
33,700
-8,200
-20% -$833K
VTYX
284
DELISTED
Ventyx Biosciences
VTYX
$1.92M 0.04%
58,463
+11,437
+24% +$394K
ROIV icon
285
Roivant Sciences
ROIV
$25.4B
$1.92M 0.04%
190,211
+28,386
+18% +$254K
NSA
286
DELISTED
National Storage Affiliates Trust
NSA
$1.91M 0.04%
54,981
-109,779
-67% -$4.14M
ZWS icon
287
Zurn Elkay Water Solutions
ZWS
$8.6B
$1.91M 0.04%
+70,891
New +$1.61M
MU icon
288
Micron Technology
MU
$996B
$1.89M 0.04%
30,000
– –
ARYE
289
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$1.88M 0.04%
181,263
-4,086
-2% -$42.1K
AGIO icon
290
Agios Pharmaceuticals
AGIO
$1.91B
$1.88M 0.04%
66,221
+13,721
+26% +$341K
TARS icon
291
Tarsus Pharmaceuticals
TARS
$2.87B
$1.87M 0.04%
103,262
+5,087
+5% +$80.9K
PTGX icon
292
Protagonist Therapeutics
PTGX
$9.46B
$1.85M 0.04%
67,094
-41,379
-38% -$1.04M
VRNA
293
DELISTED
Verona Pharma
VRNA
$1.85M 0.04%
87,628
-9,944
-10% -$212K
NFYS
294
DELISTED
Enphys Acquisition Corp.
NFYS
$1.85M 0.04%
178,033
-4,013
-2% -$41.3K
AXSM icon
295
Axsome Therapeutics
AXSM
$10.8B
$1.85M 0.04%
25,735
+3,169
+14% +$234K
SILK
296
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1.84M 0.04%
56,528
+17,046
+43% +$622K
PTCT icon
297
PTC Therapeutics
PTCT
$5.91B
$1.83M 0.04%
45,101
-9,662
-18% -$473K
RAPT
298
DELISTED
RAPT Therapeutics
RAPT
$1.81M 0.04%
12,102
+596
+5% +$92.8K
CNDA
299
DELISTED
Concord Acquisition Corp II
CNDA
$1.81M 0.04%
176,330
-3,974
-2% -$40.6K
PRCT icon
300
Procept Biorobotics
PRCT
$1.15B
$1.81M 0.04%
51,116
+9,173
+22% +$303K
10 11
12
13 14

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor's Q2 2023 filing shows 128 new, 150 increased, 259 reduced and 162 closed positions. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M. The largest sale was First Horizon, an estimated $179M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.